logo
Plus   Neg
Share
Email

Basilea: Pfizer's MAA For Cresemba Accepted For Regulatory Review In China

Basilea Pharmaceutica Ltd. (BPMUF.PK) said the marketing authorization application for the antifungal isavuconazole (Cresemba) for the treatment of adult patients with invasive aspergillosis, which was submitted by the company's license partner Pfizer (PFE), has been accepted for regulatory review by the Center for Drug Evaluation at the National Medical Products Administration of China.

Basilea Pharma noted that, under an existing license agreement with Pfizer, the company is still eligible for regulatory and sales milestone payments of up to approximately $630 million, in addition to receiving mid-teen royalties on sales.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health has started administering second doses of COVID-19 vaccine at skilled nursing facilities, which will be completed within four weeks. The company said its long-term care vaccination effort remains on track. The healthcare company has administered the first round of vaccine doses to nearly 8,000 skilled nursing facilities across the country. Goldman Sachs Group Inc. cut Chairman and Chief Executive Officer David Solomon's fiscal 2020 pay by $10 million as a penalty for the bank's role in 1Malaysia Development Berhad or 1MDB bribery scandal. In a filing with the U.S. Securities and Exchange Commission, the bank said it has also cut payments of President and Chief Operating Officer John Waldron, and Chief Financial Officer Stephen Scher Facebook has rolled out the Facebook News feature for users across the United Kingdom, the only destination outside the United States to get the feature. Facebook News comes as a tab in the Android or iOS version of the Facebook app that will feature news from hundreds of leading national, local and lifestyle outlets.
Follow RTT